Nurse-led program aims to boost survival and quality of life in lung cancer patients

NCT ID NCT05053997

Recruiting now Symptom relief Sponsor: Zealand University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a nurse-led program that includes regular symptom check-ins, guidance, and exercise can improve survival and quality of life for 250 vulnerable lung cancer patients. Participants will be randomly assigned to receive this extra support or standard care. The goal is to help patients stick to their treatment and manage symptoms better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nurse navigation, symptom monitoring, and exercise program
What this could lead to: If successful, this approach could help vulnerable lung cancer patients live longer and feel better by improving treatment adherence and managing symptoms.
What could go wrong: This is a behavioral intervention, not a drug, so benefits may be modest. The trial is still recruiting and results are not yet available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER

Contacts and locations

Locations

Aalborg University Hospital
RECRUITING

Aalborg, Denmark
Gødstrup Hospital
RECRUITING

Herning, Denmark
Odense University Hospital
RECRUITING

Odense, Denmark
Sønderborg Sygehus
RECRUITING

Sønderborg, Denmark
Vejle Sygehus
RECRUITING

Vejle, Denmark
Zealand University Hospital
RECRUITING

Roskilde, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.